IP Group Plc (LON:IPO)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 674.06M +25.7% |
| Revenue (ttm) | 38.90M |
| Net Income | 141.00M |
| EPS | 0.15 |
| Shares Out | 883.43M |
| PE Ratio | 4.96 |
| Forward PE | 16.34 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,571,480 |
| Open | 72.50 |
| Previous Close | 75.00 |
| Day's Range | 72.50 - 76.40 |
| 52-Week Range | 48.00 - 76.90 |
| Beta | 1.34 |
| Analysts | Strong Buy |
| Price Target | 116.67 (+52.91%) |
| Est. Earnings | Dec 16, 2026 |
About IP Group
IP Group Plc is a private equity and venture capital firm specializing in seed/startup, early venture, emerging growth, mature, mid venture, late venture, incubation, mezzanine in growth capital companies. It prefers to invest in energy, materials, healthcare, information technology, communication services, utilities, life sciences, deeptech, cleantech, chemicals, science and innovation companies. The firm prefers to invest in Europe, typically invests in companies based in or willing to relocate to North East England. It firm prefers to invest... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for IPO stock is "Strong Buy." The 12-month stock price target is 117p, which is an increase of 52.91% from the latest price.
News
IP Group H1 Earnings Call Highlights
IP Group LON: IPO reported higher net asset value, strong cash realizations and broad portfolio activity in the first half of 2026, while management said it remains focused on converting portfolio val...
IP Group Earnings Call Transcript: H1 2026
NAV per share rose 3% to GBP 1.14 in H1 2026, with strong cash realizations and portfolio progress. Key assets like Pfizer's obesity royalty and Oxford Nanopore drove value, while third-party capital and exits advanced toward the GBP 250 million target. Portfolio diversification, disciplined execution, and capital allocation remain priorities.
IP Group Earnings release: H1 2026
IP Group released its H1 2026 earnings on September 15, 2026, summarizing the period's financial results.
IP Group Slides: H1 2026
IP Group has posted slides in relation to its H1 2026 quarterly earnings report, which was published on September 15, 2026.
Top investor Railpen walks away from UK's IP Group
Railpen, the largest shareholder in Britain's IP Group , said on Monday that it does not intend to make another offer for the early-stage science investor as the companies could not agree on a mut...
Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group
SANTA CLARA, Calif. & OXFORD, England--(BUSINESS WIRE)-- #Mach42--Mach42 completes £7m funding round, led by IP Group with investment from BGF and Foresight Group.
UK's IP Group rebuffs Railpen's revised 71.3 pence proposal
IP Group's board of directors on Monday unanimously rejected a sweetened 71.3 pence-per-share takeover proposal from its largest shareholder, Railpen, citing significant undervaluation of the compan...
UK's IP Group gets sweetened takeover offer from top investor Railpen
Railpen, the largest shareholder in Britain's IP Group , said on Friday it has made a sweetened takeover offer for the early-stage science investor, nearly a month after IP Group rejected an earlier...
IP Group Transcript: AGM 2026
The meeting marked a leadership transition, reviewed a return to profitability, and highlighted strong cash positions and significant shareholder returns via buybacks. Strategic focus remains on long-term science investments, robust asset valuation, and navigating challenging markets.
IP Group price target raised to 110 GBp from 103 GBp at Deutsche Bank
Deutsche Bank raised the firm’s price target on IP Group (IPZYF) to 110 GBp from 103 GBp and keeps a Buy rating on the shares.
IP Group Earnings Call Transcript: H2 2025
NAV per share grew 13% year-over-year, driven by a major royalty interest in Pfizer's obesity drug, strong cash exits, and disciplined buybacks. Portfolio companies raised significant third-party capital, and the group remains focused on deep tech, clean tech, and life sciences, with robust capital allocation and new institutional partnerships.
IP Group Slides: H2 2025
IP Group has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 17, 2026.
IP Group Annual report: H2 2025
IP Group has published its H2 2025 annual report on March 17, 2026.
IP Group Annual report: H2 2025
IP Group has published its H2 2025 annual report on March 17, 2026.
IP Group price target lowered to 103 GBp from 114 GBp at Deutsche Bank
Deutsche Bank lowered the firm’s price target on IP Group (IPZYF) to 103 GBp from 114 GBp and keeps a Buy rating on the shares.
IP Group Earnings Call Transcript: H1 2025
Strong H1 2025 progress with GBP 30 million in exits, robust cash position, and NAV per share rising to GBP 1. Hinge Health IPO and Oxford Nanopore's results drove value, while buybacks accelerated and portfolio funding remains solid. Confidence is high for achieving GBP 250 million exits by 2027.
IP Group Slides: H1 2025
IP Group has posted slides in relation to its H1 2025 quarterly earnings report, which was published on September 17, 2025.
IP Group Earnings release: H1 2025
IP Group released its H1 2025 earnings on September 17, 2025, summarizing the period's financial results.
IP Group Transcript: CMD 2025
The group is leveraging its leading position in U.K. deep tech investing to capitalize on major trends in clean energy, healthcare, and digital transformation, supported by strong university partnerships and government policy shifts. Recent exits and capital inflows highlight robust financial performance and a well-developed pipeline of innovative companies.
IP Group Transcript: AGM 2025
The meeting highlighted record cash realizations, a strong cash position, and decisive cost reductions. Strategic focus remains on addressing the NAV discount, expanding buybacks, and building scale-up capital, with all AGM resolutions passed and robust shareholder engagement throughout.
IP Group Earnings Call Transcript: H2 2024
Cash exits reached GBP 183 million in 2024, outpacing a sluggish VC market, while accelerated buybacks retired over 10% of shares. Despite a 15% NAV per share decline due to write-downs in key holdings, cost reductions and a strong pipeline position the group for future growth.
IP Group Annual report: H2 2024
IP Group has published its H2 2024 annual report on March 25, 2025.
IP Group Slides: H2 2024
IP Group has posted slides in relation to its H2 2024 quarterly earnings report, which was published on March 25, 2025.
IP Group Annual report: H2 2024
IP Group has published its H2 2024 annual report on March 25, 2025.
IP Group Earnings Call Transcript: H1 2024
Portfolio exits accelerated in H1 2024, enabling significant capital returns despite a 9% NAV per share decline driven by Nanopore. Cost reductions and a strong cash position support further buybacks, while momentum is building for additional exits and value creation in H2.